FIELD: medicine.
SUBSTANCE: method involves introducing recombinant human granulocytic colony-stimulating factor.
EFFECT: enhanced effectiveness of treatment; increased number of stem cells and their improved homing in lesion foci without polypragmasia effects.
5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
MEDICATION FOR REGENERATIVE MEDICINE | 2009 |
|
RU2406528C2 |
METHOD FOR TREATING EXPERIMENTAL CHRONIC TOXIC HEPATITIS | 2005 |
|
RU2295971C1 |
AGENT POSSESSING ANTIDIABETIC ACTIVITY | 2006 |
|
RU2313361C1 |
CEREBROPROTECTIVE AGENT | 2013 |
|
RU2517282C1 |
METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
METHOD OF INTENSIFICATION OF STEM CELLS MOBILISATION | 2006 |
|
RU2330674C1 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2501562C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2497540C1 |
Authors
Dates
2006-09-20—Published
2004-12-31—Filed